• Devices
    • Medical Remanufacturing
    • Catalogue
    • Electrophysiology
      • CARTO3
      • EnSite Precision
    • Surgical Instruments
      • Harmonic
    • Purchase of used medical devices
    • eIFU
  • About us
    • Sustainability
    • Economy
    • Safety
    • AMDR
  • Career
  • News
  • Downloads
    • eIFU
  • Contact
  • LogIn
  • English
    • Deutsch
    • English
    • Español
    • Nederlands
    • Français
    • Svenska
    • Dansk
    • Português
    • Norsk Bokmål
Sustainability at Vanguard: Three Pillars for the same goal

Sustainability at Vanguard: Three Pillars for the same goal

by Clemens Köhler | 5. February 2025 | News (en)

1. Environmental sustainability: Taking responsibility for the Planet As a manufacturer of remanufactured medical devices, resource conservation is a top priority for us. Through remanufacturing, we extend the lifespan of medical products to maximise their use. The...
The Netherlands allows CS reprocessing from the turn of the year

The Netherlands allows CS reprocessing from the turn of the year

by Clemens Köhler | 23. January 2025 | News (en)

What does it mean in practice? Unlike CE reprocessing, CS reprocessing is carried out without the full obligations of the original manufacturer, as regulated by the respective national legislation. The healthcare facility retains ownership of its devices, which means...
The Future of Medical Technology in the UK: A Roadmap to the Circular Economy

The Future of Medical Technology in the UK: A Roadmap to the Circular Economy

by Clemens Köhler | 7. January 2025 | News (en)

The UK healthcare sector is on the brink of a revolution. The Department of Health & Social Care has published the “Design for Life Roadmap,” a strategic plan to make medical technology more sustainable. The goal is ambitious: By 2045, the UK intends...
More Sustainability, Lower Costs: 5 Reasons Why Medical Remanufacturing Makes Sense

More Sustainability, Lower Costs: 5 Reasons Why Medical Remanufacturing Makes Sense

by Clemens Köhler | 19. December 2024 | News (en)

Reducing emissions The healthcare sector is a true “CO2 emitter”. A single hospital bed, for example, consumes as much energy annually as four-family homes. Despite its massive environmental impact, the medical industry is not yet a primary target of climate-focused...
Article 17 of the MDR Declares: Reprocessors Are Manufacturers

Article 17 of the MDR Declares: Reprocessors Are Manufacturers

by Clemens Köhler | 6. December 2024 | News (en)

Reprocessing of Medical Devices: What the MDR Stipulates While Article 17 of the MDR provides unified, detailed European requirements for reprocessing single-use devices—replacing previous national regulations— EU-wide harmonization is not fully achieved. Each member...
Sustainability in Medicine: Remanufacturing Single-Use Devices on the Rise

Sustainability in Medicine: Remanufacturing Single-Use Devices on the Rise

by Clemens Köhler | 18. November 2024 | News (en)

A Success Story: The UK Leads the Way Stepping Hill Hospital, part of the Stockport NHS Foundation Trust, has demonstrated the effectiveness of remanufacturing through its Green Plan and the introduction of a single-use device remanufacturing program. In 2023/24...
« Older Entries
Next Entries »

Recent Posts

  • Four perspectives, one shared goal: introducing our Executive Support Team
  • Hygienic, safe, compliant: CE, CS and KRINKO in remanufacturing practice
  • TÜV NORD Awards First MDR Certificate for CE Reprocessing to Vanguard AG
  • Agroforestry Project Update: A Diverse Ecosystem Is Taking Shape on Field 701
  • Why We Need to Talk About “Scope 4” and the Contribution Remanufacturing Can Make

Recent Comments

No comments to show.

Vanguard AG
Landsberger Str. 222
12623 Berlin
Deutschland
Kundenservice: 030 - 318 73 43 - 300

Vanguard Medical Devices Limited
The Scalpel, 18th Floor, 52 Lime Street
London EC3M 7AF
UK

International customer service:
+49 30 - 318 73 43 - 300

© 2026 Vanguard AG. All rights reserved.

Impressum   Datenschutzerklärung   AGB   Kontakt   Datenschutzhinweise für Aktionäre